The histone deacetylase inhibitor valproic acid sensitizes human and canine osteosarcoma to doxorubicin

Por Wittenburg, Luke A., Bisson, Liam, Rose, Barbara J., Korch, Christopher, Thamm, Douglas H.
Publicado em 2010

An Asymmetric Synthesis of 1,2,4-Trioxane Anticancer Agents via Desymmetrization of Peroxyquinols through a Brønsted Acid Catalysis Cascade

Por Rubush, David M., Morges, Michelle A., Rose, Barbara J., Thamm, Douglas H., Rovis, Tomislav
Publicado em 2012

DNA Repair Deficiency as a Susceptibility Marker for Spontaneous Lymphoma in Golden Retriever Dogs: A Case-Control Study

Por Thamm, Douglas H., Grunerud, Kristen K., Rose, Barbara J., Vail, David M., Bailey, Susan M.
Publicado em 2013

Intrinsic Radiosensitivity and Cellular Characterization of 27 Canine Cancer Cell Lines

Por Maeda, Junko, Froning, Coral E., Brents, Colleen A., Rose, Barbara J., Thamm, Douglas H., Kato, Takamitsu A.
Publicado no PLoS One (2016)

Development of an in vitro model of acquired resistance to toceranib phosphate (Palladia®) in canine mast cell tumor

Por Halsey, Charles HC, Gustafson, Daniel L, Rose, Barbara J, Wolf-Ringwall, Amber, Burnett, Robert C, Duval, Dawn L, Avery, Anne C, Thamm, Douglas H
Publicado em 2014

Comparative Pharmacokinetic Properties and Antitumor Activity of the Marine HDACi Largazole and Largazole Peptide Isostere

Por Pilon, John L., Clausen, Dane J., Hansen, Ryan J., Lunghofer, Paul J., Charles, Brad, Rose, Barbara J., Thamm, Douglas H., Gustafson, Daniel L., Bradner, James E., Williams, Robert M.
Publicado no Cancer Chemother Pharmacol (2015)

Genomic Instability and Telomere Fusion of Canine Osteosarcoma Cells

Por Maeda, Junko, Yurkon, Charles R., Fujisawa, Hiroshi, Kaneko, Masami, Genet, Stefan C., Roybal, Erica J., Rota, Garrett W., Saffer, Ethan R., Rose, Barbara J., Hanneman, William H., Thamm, Douglas H., Kato, Takamitsu A.
Publicado em 2012